Activation of matrix metalloproteinases 2, 9, and 13 by activated protein c in human osteoarthritic cartilage chondrocytes

Arthritis and Rheumatology

Volumn 66, Issue 6, 2014, Pages 1525-1536

  Jackson, Miriam T ^a,c   Moradi, Babak ^a,b,c   Smith, Margaret M ^a,c   Jackson, Christopher J ^a,c   Little, Christopher B ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; AGGRECAN; AGGRECANASE; COLLAGEN; COLLAGENASE 3; ENDOTHELIAL PROTEIN C RECEPTOR; GELATIN; GELATINASE A; GELATINASE B; INTERLEUKIN 1ALPHA; INTERSTITIAL COLLAGENASE; MESSENGER RNA; PROTEIN C; PROTEINASE ACTIVATED RECEPTOR 1; SERINE PROTEINASE INHIBITOR; THROMBOMODULIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

AGED; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; WESTERN BLOTTING; ZYMOGRAPHY;

AGED; AGED, 80 AND OVER; AGGRECANS; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; COLLAGEN; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; OSTEOARTHRITIS, KNEE; PROTEIN C; SERINE PROTEASES; SYNOVIAL FLUID; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 84901594083     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38401     Document Type: Article

References (43)

1. Freemont AJ, Hampson V, Tilman R, Goupille P, Taiwo Y, Hoyland JA,. Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific. Ann Rheum Dis 1997; 56: 542-9.
2. Buisson-Legendre N, Smith S, March L, Jackson C,. Elevation of activated protein C in synovial joints in rheumatoid arthritis and its correlation with matrix metalloproteinase 2. Arthritis Rheum 2004; 50: 2151-6.
3. Hackeng TM, Tans G, Koppelman SJ, de Groot PG, Rosing J, Bouma BN,. Protein C activation on endothelial cells by prothrombin activation products generated in situ: meizothrombin is a better protein C activator than α-thrombin. Biochem J 1996; 319: 399-405.
4. Stenflo J,. A new vitamin K-dependent protein: purification from bovine plasma and preliminary characterization. J Biol Chem 1976; 251: 355-63.
5. Dahlback B, Villoutreix BO,. The anticoagulant protein C pathway. FEBS Lett 2005; 579: 3310-6.
6. Haley PE, Doyle MF, Mann KG,. The activation of bovine protein C by factor Xa. J Biol Chem 1989; 264: 16303-10.
7. Esmon CT,. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989; 264: 4743-6.
8. Griffin JH, Fernandez JA, Gale AJ, Mosnier LO,. Activated protein C. J Thromb Haemost 2007; 5 Suppl 1: 73-80.
9. Jackson CJ, Xue M,. Activated protein C-an anticoagulant that does more than stop clots. Int J Biochem Cell Biol 2008; 40: 2692-7.
10. Grey ST, Hancock WW,. A physiologic anti-inflammatory pathway based on thrombomodulin expression and generation of activated protein C by human mononuclear phagocytes. J Immunol 1996; 156: 2256-63.
11. White B, Schmidt M, Murphy C, Livingstone W, O'Toole D, Lawler M, et al. Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor κB (NF-κB) and tumour necrosis factor α (TNF-α) production in the THP-1 monocytic cell line. Br J Haematol 2000; 110: 130-4.
12. Jackson CJ, Xue M, Thompson P, Davey RA, Whitmont K, Smith S, et al. Activated protein C prevents inflammation yet stimulates angiogenesis to promote cutaneous wound healing. Wound Repair Regen 2005; 13: 284-94.
13. Xue M, Thompson P, Kelso I, Jackson C,. Activated protein C stimulates proliferation, migration and wound closure, inhibits apoptosis and upregulates MMP-2 activity in cultured human keratinocytes. Exp Cell Res 2004; 299: 119-27.
14. Itoh T, Matsuda H, Tanioka M, Kuwabara K, Itohara S, Suzuki R,. The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis. J Immunol 2002; 169: 2643-7.
15. Duerr S, Stremme S, Soeder S, Bau B, Aigner T,. MMP-2/gelatinase A is a gene product of human adult articular chondrocytes and is increased in osteoarthritic cartilage. Clin Exp Rheumatol 2004; 22: 603-8.
16. Jackson MT, Smith MM, Smith SM, Jackson CJ, Xue M, Little CB,. Activation of cartilage matrix metalloproteinases by activated protein C. Arthritis Rheum 2009; 60: 780-91.
17. Little CB, Hughes CE, Curtis CL, Janusz MJ, Bohne R, Wang-Weigand S, et al. Matrix metalloproteinases are involved in C-terminal and interglobular domain processing of cartilage aggrecan in late stage cartilage degradation. Matrix Biol 2002; 21: 271-88.
18. Bau B, Gebhard PM, Haag J, Knorr T, Bartnik E, Aigner T,. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum 2002; 46: 2648-57.
19. Little CB, Flannery CR, Hughes CE, Mort JS, Roughley PJ, Dent C, et al. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Biochem J 1999; 344: 61-8.
20. Chan BY, Fuller ES, Russell AK, Smith SM, Smith MM, Jackson MT, et al. Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis. Osteoarthritis Cartilage 2011; 19: 874-85.
21. Xu Y, Barter MJ, Swan DC, Rankin KS, Rowan AD, Santibanez-Koref M, et al. Identification of the pathogenic pathways in osteoarthritic hip cartilage: commonality and discord between hip and knee OA. Osteoarthritis Cartilage 2012; 20: 1029-38.
22. Ellerbroek SM, Wu YI, Overall CM, Stack MS,. Functional interplay between type I collagen and cell surface matrix metalloproteinase activity. J Biol Chem 2001; 276: 24833-42.
23. Ellerbroek SM, Wu YI, Stack MS,. Type I collagen stabilization of matrix metalloproteinase-2. Arch Biochem Biophys 2001; 390: 51-6.
24. Freise C, Erben U, Muche M, Farndale R, Zeitz M, Somasundaram R, et al. The α2 chain of collagen type VI sequesters latent proforms of matrix-metalloproteinases and modulates their activation and activity. Matrix Biol 2009; 28: 480-9.
25. Gilles C, Bassuk JA, Pulyaeva H, Sage EH, Foidart JM, Thompson EW,. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines. Cancer Res 1998; 58: 5529-36.
26. Huet E, Brassart B, Cauchard JH, Debelle L, Birembaut P, Wallach J, et al. Cumulative influence of elastin peptides and plasminogen on matrix metalloproteinase activation and type I collagen invasion by HT-1080 fibrosarcoma cells. Clin Exp Metastasis 2002; 19: 107-17.
27. Nguyen M, Arkell J, Jackson CJ,. Three-dimensional collagen matrices induce delayed but sustained activation of gelatinase A in human endothelial cells via MT1-MMP. Int J Biochem Cell Biol 2000; 32: 621-31.
28. Su J, Yu J, Ren T, Zhang W, Zhang Y, Liu X, et al. Discoidin domain receptor 2 is associated with the increased expression of matrix metalloproteinase-13 in synovial fibroblasts of rheumatoid arthritis. Mol Cell Biochem 2009; 330: 141-52.
29. Utani A, Momota Y, Endo H, Kasuya Y, Beck K, Suzuki N, et al. Laminin α3 LG4 module induces matrix metalloproteinase-1 through mitogen-activated protein kinase signaling. J Biol Chem 2003; 278: 34483-90.
30. Cawston T, Billington C, Cleaver C, Elliott S, Hui W, Koshy P, et al. The regulation of MMPs and TIMPs in cartilage turnover. Ann N Y Acad Sci 1999; 878: 120-9.
31. Knott I, Dieu M, Burton M, Lecomte V, Remacle J, Raes M,. Differential effects of interleukin-1 α and β on the arachidonic acid cascade in human synovial cells and chondrocytes in culture. Agents Actions 1993; 39: 126-31.
32. Little CB, Flannery CR, Hughes CE, Goodship A, Caterson B,. Cytokine induced metalloproteinase expression and activity does not correlate with focal susceptibility of articular cartilage to degeneration. Osteoarthritis Cartilage 2005; 13: 162-70.
33. Garvican ER, Vaughan-Thomas A, Redmond C, Gabriel N, Clegg PD,. MMP-mediated collagen breakdown induced by activated protein C in equine cartilage is reduced by corticosteroids. J Orthop Res 2010; 28: 370-8.
34. Kevorkian L, Young DA, Darrah C, Donell ST, Shepstone L, Porter S, et al. Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum 2004; 50: 131-41.
35. Aigner T, Zien A, Gehrsitz A, Gebhard PM, McKenna L,. Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum 2001; 44: 2777-89.
36. Swingler TE, Waters JG, Davidson RK, Pennington CJ, Puente XS, Darrah C, et al. Degradome expression profiling in human articular cartilage. Arthritis Res Ther 2009; 11: R96.
37. Tetlow LC, Adlam DJ, Woolley DE,. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum 2001; 44: 585-94.
38. Fan Z, Bau B, Yang H, Soeder S, Aigner T,. Freshly isolated osteoarthritic chondrocytes are catabolically more active than normal chondrocytes, but less responsive to catabolic stimulation with interleukin-1β. Arthritis Rheum 2005; 52: 136-43.
39. Shapiro SD, Fliszar CJ, Broekelmann TJ, Mecham RP, Senior RM, Welgus HG,. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate: differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP). J Biol Chem 1995; 270: 6351-6.
40. Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W,. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 2002; 296: 1880-2.
41. Kobayashi M, Squires GR, Mousa A, Tanzer M, Zukor DJ, Antoniou J, et al. Role of interleukin-1 and tumor necrosis factor α in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum 2005; 52: 128-35.
42. Toth M, Chvyrkova I, Bernardo MM, Hernandez-Barrantes S, Fridman R,. Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes. Biochem Biophys Res Commun 2003; 308: 386-95.
43. Milner JM, Patel A, Davidson RK, Swingler TE, Desilets A, Young DA, et al. Matriptase is a novel initiator of cartilage matrix degradation in osteoarthritis. Arthritis Rheum 2010; 62: 1955-66.